Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00913159 · ClinicalTrials.gov registry record · NA
A Trial Comparing Efficacy of HM3 Versus F2 Lithotripters for Stone Fragmentation
A NA study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT00913159: Clinical Trial NA study, sponsored by Washington University School of Medicine.
NCT00913159 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00913159, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The older lithotripter, HM3, has over 90% stone-free rate in most studies. However, it's less transportable than the new model, F2. There are no prospective trials performed to make a valid comparison between these 2 lithotripters in terms of efficacy of stone fragmentation and clinical outcomes.
Interventions
- PROCEDURE Extracorporeal Shock Wave Lithotripsy (ESWL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-08 |
| Phase | NA |
Why NCT00913159 stopped before completion
NCT00913159 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Extracorporeal Shock Wave Lithotripsy (ESWL) is the first listed.
NCT00913159 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00913159 about?
NCT00913159 is a clinical study titled "A Trial Comparing Efficacy of HM3 Versus F2 Lithotripters for Stone Fragmentation". The older lithotripter, HM3, has over 90% stone-free rate in most studies. However, it's less transportable than the new model, F2. There are no prospective trials performed to make a valid comparison between these 2 lithotripters in terms of efficacy of stone fragmentation and clinical outcomes.
What is the current status of trial NCT00913159?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2009-11. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00913159?
The interventions under investigation include: Extracorporeal Shock Wave Lithotripsy (ESWL) (PROCEDURE).
Who is sponsoring clinical trial NCT00913159?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00913159's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia